pinocembrin has been researched along with phenylethyl alcohol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Lohidasan, S; Mahadik, KR; Sadhana, N | 1 |
| da Silva, CCS; Fontes-Júnior, EA; Luz, DA; Maia, CSF; Martins, MAT; Martins, MD; Menezes da Silveira, CCS; Prediger, RDS | 1 |
| Belduz, AO; Guler, HI; Kolayli, S; Tatar, G; Yildiz, O | 1 |
1 review(s) available for pinocembrin and phenylethyl alcohol
| Article | Year |
|---|---|
Propolis: A useful agent on psychiatric and neurological disorders? A focus on CAPE and pinocembrin components.
Topics: Animals; Bees; Caffeic Acids; Flavanones; Humans; Nervous System Diseases; Phenylethyl Alcohol; Propolis | 2021 |
2 other study(ies) available for pinocembrin and phenylethyl alcohol
| Article | Year |
|---|---|
Marker-based standardization and investigation of nutraceutical potential of Indian propolis.
Topics: Animals; Antioxidants; Bees; Caffeic Acids; Chromatography, High Pressure Liquid; Dietary Supplements; Ethanol; Flavanones; Flavonoids; Humans; India; Nutritive Value; Phenylethyl Alcohol; Plant Extracts; Polyphenols; Propolis | 2017 |
Investigation of potential inhibitor properties of ethanolic propolis extracts against ACE-II receptors for COVID-19 treatment by molecular docking study.
Topics: Angiotensin-Converting Enzyme 2; Animals; Bees; Caffeic Acids; COVID-19 Drug Treatment; Flavanones; Flavonoids; Hesperidin; Humans; Luteolin; Molecular Docking Simulation; Phenylethyl Alcohol; Plant Extracts; Propolis; Quercetin; Rutin | 2021 |